Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

Signaling insulin resistance in obesity

August 6, 2009 7:00 AM UTC

Researchers at Monash University have made a case for PEDF as a missing link between obesity and insulin resistance that leads to diabetes.1 However, the adipose-secreted cytokine has many biological roles, which could make it difficult for scientists to develop an inhibitor that only alters PEDF's insulin-resistance effects in obesity.

According to the Centers for Disease Control and Prevention (CDC), the prevalence of obesity in U.S. adults diagnosed with diabetes was 85.2% in 1999-2002.2 Finding a mechanistic link between the two conditions could lead to ways to prevent diabetes in the obese population...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article